Discontinuing Trazodone and Transitioning to Low-Dose Doxepin
You should gradually taper trazodone over several weeks to months using the smallest possible dose reductions, while explaining to your patient that low-dose doxepin (3-6 mg) has superior evidence for insomnia compared to trazodone, which current guidelines explicitly recommend against for chronic insomnia.
Why Stop Trazodone
The 2020 VA/DoD guidelines advise against using trazodone for chronic insomnia disorder 1. The evidence is clear: systematic reviews found no differences in sleep efficiency or discontinuation rates between trazodone and placebo, and while trazodone showed some improvement in subjective sleep quality, it had no effect on sleep onset latency, total sleep time, or wake after sleep onset 1. The low-quality evidence supporting trazodone's efficacy is outweighed by its adverse effect profile 1.
Older 2008 guidelines similarly note that trazodone's efficacy for insomnia "is not well established" and it is not FDA-approved for this indication 2.
Why Low-Dose Doxepin is Better
Low-dose doxepin (3 or 6 mg) has demonstrated efficacy in randomized controlled trials specifically for insomnia, unlike trazodone 1. Key benefits include:
- Improved insomnia severity scores at week 4 in older adults with 3-6 mg doses
- Better subjective sleep latency, total sleep time, and sleep quality in both older and younger adults
- No statistically significant differences in adverse event rates compared to placebo in clinical trials 1
- Fewer anticholinergic effects at low doses compared to traditional antidepressant doses 2
The 2020 VA/DoD guidelines specifically recommend considering low-dose doxepin (3 or 6 mg) as an appropriate pharmacologic option when behavioral interventions are unavailable or refused 1.
Tapering Schedule for Trazodone
Use a gradual, hyperbolic taper over weeks to months 2:
Specific Tapering Approach:
Reduce by the smallest increment possible in successive steps of at least several days' duration 2
Consider frequency tapering (every other night, then every third night) in addition to dose reduction to minimize rebound effects 2
Expect the taper to take several weeks to months for successful discontinuation 2
Watch for withdrawal symptoms: Despite gradual tapering, trazodone withdrawal can occur due to its effects on the serotonergic system and short half-life 3. Symptoms may include noradrenergic rebound phenomena
Revert to previous dose if withdrawal symptoms emerge, then slow the taper further 2
Common Pitfalls to Avoid:
- Don't use linear reductions (e.g., cutting 25 mg every week). This produces increasingly large pharmacological changes as you approach zero
- Don't taper too quickly. Research shows that very slow tapers (over months) are more successful than rapid tapers over days or weeks 4
- The final doses matter most. The last reductions from very low doses (even as small as 6.25-12.5 mg) can produce significant withdrawal because of the hyperbolic dose-response relationship 4
Practical Example:
If your patient is on trazodone 100 mg:
- Week 1-2: 75 mg
- Week 3-4: 50 mg
- Week 5-6: 37.5 mg (may need to use liquid formulation or split tablets)
- Week 7-8: 25 mg
- Week 9-10: 12.5 mg
- Week 11-12: Every other night dosing at 12.5 mg
- Week 13+: Discontinue
Adjust this timeline based on withdrawal symptoms—some patients may need a much slower taper.
Initiating Low-Dose Doxepin
Start doxepin 3 mg at bedtime after completing or during the final stages of the trazodone taper 1. You can increase to 6 mg if needed for efficacy. These low doses are specifically for insomnia and are far below antidepressant doses (which start at 75 mg) 5.
Important counseling point: While low-dose doxepin has no black box warning for suicide risk at these doses, the risk for suicidal ideation cannot be completely excluded 1.